Health knowledge and news provided by doctors.

Ads by Google

Lung Cancer

Genomic Signatures Identify Targeted Therapies For Lung Cancer

Any number of things can go wrong in the cells of the body to cause cancer -- and clinicians can't tell by just looking at a tumor what exactly triggered the once normal cells to turn cancerous.

New tests developed by researchers at Duke University can determine the precise patterns among thousands of genes to identify the cascade of events, or pathway, that led to the cancer.


Avastin Plus Chemotherapy May Help Non-Small Cell Lung Cancer

Genentech today announced that a Roche-sponsored, randomized placebo controlled Phase III clinical study (AVAiL) demonstrated that Avastin (bevacizumab), studied at two different doses in combination with gemcitabine and cisplatin chemotherapy, significantly increased the time patients with advanced non-small cell lung cancer (NSCLC) lived without their disease advancing, as defined by progression-free survival (PFS).